Skip to main content

RedHill Biopharma Ltd.

RDHL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001553846

In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $1.41K in total
1
13F holdersQ2 2026, −2 vs. previous quarter
14
13F valueReported value at the end of Q2 2026
$270.0K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding RDHL, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding RDHL at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by RedHill Biopharma Ltd. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 13, 2026 (view filing)4:03 PM ETJul 103 daysRaday GileadChief Operating OfficerSSale−14.1M$0.0001−$1.41K−6.1%218.8M after
Apr 22, 2026 (view filing)Apr 616 daysLateRaday GileadChief Operating OfficerSSale−15.7M$0.00$0−5.7%261.1M after

Top 10 13F holders, Q2 2026

The largest institutional positions in RedHill Biopharma Ltd. at the end of Q2 2026; share changes are against Q1 2026.

See all 14 holders
Institutions holding RDHL in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Yorkville Advisors Global, LP122,131$106.7K0.12%−228,739−65.2%Reduced
Gagnon Securities LLC88,405$74.7K0.01%00.0%Unchanged
Citadel Advisors LLC65,321$55.2K0.00%+44,648+216.0%Added
Rhumbline Advisers13,755$11.6K0.00%+8,639+168.9%Added
Lido Advisors, LLC11,009$9.30K0.00%+11,009New
GAMMA Investing LLC6,957$5.88K0.00%+273+4.1%Added
Citigroup Inc4,378$3.70K0.00%+4,378New
Federation des caisses Desjardins du Quebec3,388$2.86K0.00%00.0%Unchanged
UBS Group AG100$850.00%−726−87.9%Reduced
SBI Securities Co., Ltd.15$130.00%+11+275.0%Added